Iranian Journal of Basic Medical Sciences

Iranian Journal of Basic Medical Sciences

LC-MS-based metabolomic profiling and anti-acetylcholinesterase study of selected Salvia subg. Perovskia species

Document Type : Original Article

Authors
1 Department of Production and Utilization of Medicinal Plants, Faculty of Agriculture, University of Saravan, Saravan, Sistan and Baluchestan, Iran
2 Dipartimento di Farmacia, Università degli Studi di Salerno, Via Giovanni Paolo II 132, Fisciano, SA 84084, Italy
3 Dipartimento di Farmacia, Universit`a degli Studi di Salerno, Via Giovanni Paolo II 132, Fisciano, SA 84084, Italy
10.22038/ijbms.2026.95707.20637
Abstract
Objective(s): This study focused on three Salvia subg. Perovskia species, Salvia yangii, Salvia abrotanoides, and Salvia artemisioides, aromatic perennials native to Iran’s Baluchestan region and traditionally used in European, Chinese, Iranian, and Ayurvedic medicine to manage memory impairment and dementia. The research aimed to characterize their extracts and essential oil (EO) metabolites, and to evaluate their anti-acetylcholinesterase potential to identify bioactive compounds associated with cognitive health.
Materials and Methods: In this study, a high-performance liquid chromatography-based approach coupled with linear ion trap-Orbitrap mass spectrometry (HPLC-LTQ-Orbitrap) and GC-MS techniques were used for metabolomics of extracts and essential oils, respectively. Four pure compounds (carnosol, carnosic acid, cryptotanshinone, and 1α-hydroxydemethylsalvicanol), as well as extracts and EOs, were tested for their ability to inhibit acetylcholinesterase using the Ellman method.
Results: LC-MS analysis of ethyl acetate extracts revealed 55 compounds, most of which were diterpenoids. The primary components found in all three species were carnosol, deoxocarnosol, carnosic acid, rosmanol, and ethoxyrosmanol. The most effective inhibitors of acetylcholinesterase (AChE) were found to be the pure substances cryptotanshinone and 1α-hydroxydemethylsalvicanol, which demonstrated 15.78±0.1% and 12.17±0.1% inhibition at 450 μg/ml, respectively. The EtOAc extract of Salvia abrotanoides aerial part (AP) showed 12.96%±0.1% inhibition, while S. atriplicifulia AP showed 7.83%±0.3% inhibition. EOs were weak inhibitors, not exceeding 5%.
Conclusion: The findings indicate that pure compounds from selected plants hold promise for developing dietary supplements for Alzheimer’s disease (AD), whereas extracts and EOs exhibited limited effects and no significant synergy.
Keywords
Subjects

1. Ghahreman A. Colorful flora of Iran. 1st ed. Research Institute of Forests and Rangelands; 1979.
2. Jamzad Z. A survey of Lamiaceae in the flora of Iran. Rostaniha 2013; 14: 59–67.
3. Perry EK, Pickering AT, Wang WW, Houghton P, Perry NS. Medicinal plants and Alzheimer’s disease: Integrating ethnobotanical and contemporary scientific evidence. J Altern Complement Med 1998; 4: 419–428.
4. Perry EK, Pickering AT, Wang WW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: From ethnobotany to phytotherapy. J Pharm Pharmacol 1999; 51: 527–34.
5. Dabaghian F, Delnavazi MR, Hariri R, Akbarzadeh T, Tayarani-Najaran Z, Shams Ardekani MR, et al. Neuroprotective, and memory enhancement effects of Salvia aristata and its phenolic constituents: an in vitro, and in vivo study. BMC Complement Med Ther 2025; 25: 1-18.
6. Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK. In vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000; 52: 895–902.
7. Sadeghi Z, Masullo M, Cerulli A, Nazzaro F, Farimani MM, Piacente S. Terpenoid constituents of Perovskia artemisioides aerial parts with inhibitory effects on bacterial biofilm growth. J Nat Prod 2020; 84: 26–36.
8. Alizadeh Z, Farimani MM, Parisi V, Marzocco S, Ebrahimi SN, De Tommasi N. Nor-abietane diterpenoids from Perovskia abrotanoides roots with anti-inflammatory potential. J Nat Prod 2021; 84: 1185–1197.
9. Lopresti AL. Salvia (Sage): A review of its potential cognitive-enhancing and protective effects. Drugs R D 2017; 17: 53–64.
10. Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003; 75: 651–659.
11. Ślusarczyk S, Senol Deniz FS, Abel R, Pecio Ł, Pérez-Sánchez H, Ceron-Carrasco JP, et al. Norditerpenoids with selective anti-cholinesterase activity from the roots of Perovskia atriplicifolia benth. Int J Mol Sci 2020; 21: 1-17.
12. Bhavya M, Chandu A, Devi SS. Ocimum tenuiflorum oil, a potential insecticide against rice weevil with anti-acetylcholinesterase activity. Ind Crops Prod 2018; 126: 434–439.
13. Sadeghi Z, Farimani MM, Khorrami F, Abdollahi V. Insecticidal and oviposition deterrent effects of pure and combined essential oils of Salvia subg. Perovskia species against Phthorimaea operculella. S Afr J Bot 2022; 151: 126–132.
14. Sadeghi Z, Cerulli A, Marzocco S, Moridi Farimani M, Masullo M, Piacente S. Anti-inflammatory activity of tanshinone-related diterpenes from Perovskia artemisioides roots. J Nat Prod 2023; 86: 812–821.
15. Mazouz W, Haouli NEH, Gali L, Vezza T, Bensouici C, Mebrek S, et al. Anti-oxidant, anti-alzheimer, anti-diabetic, and anti-inflammatory activities of the endemic halophyte Limonium spathulatum (Desf.) kuntze on LPS-stimulated RAW264 macrophages. S Afr J Bot 2020; 135: 101–108.
16. Yilmaz G, Eruygur N, Bona GE, Bona M, Akdeniz M, Yilmaz MA, et al. Phytochemical analysis, anti-oxidant, and enzyme inhibition activity of five Salvia taxa from Turkey. S Afr J Bot 2023; 152: 212–221.
17. Parisi V, Santoro V, Donadio G, Bellone ML, Diretto G, Sandri C, et al. Comparative chemical analysis of eight Punica granatum L. Peel cultivars and their anti-oxidant and anti-inflammatory activities. Antioxidants 2022; 11: 2262-2279.
18. Ebrahimi SN, Hadian J, Mirjalili M, Sonboli A, Yousefzadi M. Essential oil composition and antibacterial activity of Thymus caramanicus at different phenological stages. Food Chem 2008; 110: 927–931.
19. Adams RP. Identification of Essential Oil Components by Gas Chromatography/ Mass Spectrometry 4th ed. Allured Publishing Corp, Carol Stream, IL, USA. 2007.
20. Ellman GL, Courtney KD, Andres Jr V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95.
21. Hu P, Liang Q-L, Luo G-A, Zhao Z-Z, Jiang Z-H. Multi-component HPLC fingerprinting of Radix Salviae Miltiorrhizae and its LC-MS-MS identification. Chem Pharm Bull 2005; 53: 677–683.
22. Wang L, Gan C, Wang Z, Liu L, Gao M, Li Q, et al. Determination and pharmacokinetic study of three diterpenes in rat plasma by UHPLC-ESI-MS/MS after oral administration of Rosmarinus officinalis L. extract. Molecules 2017; 22: 934-946.
23. Xu LL, Guo FX, Chi SS, Wang ZJ, Jiang YY, Liu B, et al. Rapid screening and identification of diterpenoids in Tinospora sinensis based on high-performance liquid chromatography coupled with linear ion trap-Orbitrap mass spectrometry. Molecules 2017; 22: 912-929
24. Yan S-l, Li K-l, Yang Q-r, Yu K-q, Liu L, Li Q, et al. Analysis of the chemical constituents of Rhodobryum roseum based on UHPLC-Q-Exactive Orbitrap Mass Spectrometry. Nat Prod Commun 2024; 19: 1-11.
25. Perveen S, Al-Taweel A, Fawzy G, Ibrahim T, Malik A, Khan A. Cholinesterase inhibitory triterpenes from Perovskia atriplicifolia. Asian J Chem 2014; 26: 6163-6170.
26. Wong KK-K, Ngo JC-K, Liu S, Lin H-q, Hu C, Shaw P-C, et al. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis. Chem Biol Interact 2010; 187: 335–339.
27. Taqui R, Debnath M, Ahmed S, Ghosh A. Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer’s disease. Phytomed Plus 2022; 2: 100184-100194.
28. Moreira NCdS, Lima JEBdF, Marchiori MF, Carvalho I, Sakamoto-Hojo ET. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives. J Alzheimer’s Dis Rep 2022; 6: 177–193.
29. Yung-Chi C, Prusoff WH. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099–3108.
30. Jamshidnejad-Tosaramandani T, Kashanian S, Babaei M, Al-Sabri MH, Schiöth HB. The potential effect of insulin on AChE and its interactions with rivastigmine in vitro. Pharmaceuticals 2021; 14: 1136-1147.
31. Ayoub IM, George MY, Menze ET, Mahmoud M, Botros M, Essam M, et al. Insights into the neuroprotective effects of Salvia officinalis L. and Salvia microphylla Kunth in the memory impairment rat model. Food Funct 2022; 13: 2253–2268.
32. Cui W-B, Zhang Z-P, Bai X, Wang S-S, Chen X-H, Liu X, et al. Cryptotanshinone alleviates oxidative stress and reduces the level of abnormally aggregated protein in Caenorhabditis Elegans AD models. Int J Mol Sci 2022; 23: 10030-10047.
33. Ding H, Kan S, Wang X, Du B, Mou Y, Dong R, et al. Cryptotanshinone against vascular dementia through inhibition of Aβ aggregation and inflammatory responses in cerebrovascular endothelial cells. Arab J Chem 2022; 15: 104328-104336.
34. Merad M, Soufi W, Ghalem S, Boukli F, Baig M, Ahmad K, et al. Molecular interaction of acetylcholinesterase with carnosic acid derivatives: A neuroinformatics study. CNS Neurol Disord-Drug Targets 2014; 13: 440–446.
35. Habtemariam S. Anti-inflammatory therapeutic mechanisms of natural products: insight from rosemary diterpenes, carnosic acid and carnosol. Biomedicines 2023; 11: 545-571.
36. Mirza FJ, Zahid S, Holsinger RD. Neuroprotective effects of carnosic acid: Insight into its mechanisms of action. Molecules 2023; 28: 2306-2319.
37. Ahammed S, Afrin R, Uddin N, Al-Amin Y, Hasan K, Haque U, et al. Acetylcholinesterase inhibitory and antioxidant activity of the compounds isolated from vanda roxburghii. Adv Pharmacol Pharm Sci 2021; 2021: 1-9.
38. Gharehbagh HJ, Ebrahimi M, Dabaghian F, Mojtabavi S, Hariri R, Saeedi M, et al. Chemical composition, cholinesterase, and α-glucosidase inhibitory activity of the essential oils of some Iranian native Salvia species. BMC Complement Med Ther 2023; 23: 184-200.
39. Kocer M, İstifli ES. Chemical composition and cholinesterase, tyrosinase, alpha-amylase and alpha-glucosidase inhibitory activity of the essential oil of Salvia tomentosa. Int J Plant Bas Pharm 2022; 2: 1–16.

Articles in Press, Accepted Manuscript
Available Online from 26 September 2026